These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3534484)

  • 1. The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds.
    Markey SP; Schmuff NR
    Med Res Rev; 1986; 6(4):389-429. PubMed ID: 3534484
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology and biochemical mechanisms involved in MPTP-induced parkinsonism.
    Poirier J
    J Am Geriatr Soc; 1987 Jul; 35(7):660-8. PubMed ID: 3108351
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion.
    Chacon JN; Chedekel MR; Land EJ; Truscott TG
    Biochem Biophys Res Commun; 1987 Apr; 144(2):957-64. PubMed ID: 3495270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid peroxidation in the caudate nuclei in experimental parkinsonian syndrome].
    Kucherianu VG; Atadzhanov MA; Nikushkin EV; Zagorevskiĭ VA; Sharkova LM
    Biull Eksp Biol Med; 1989 Jan; 107(1):39-41. PubMed ID: 2783652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
    Langston JW; Langston EB; Irwin I
    Acta Neurol Scand Suppl; 1984; 100():49-54. PubMed ID: 6333134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the '4-5' double bond for neurotoxicity in primates of the pyridine derivative MPTP.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Sep; 50(1-3):289-94. PubMed ID: 6333656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes as a primary locus for the conversion MPTP into MPP+.
    Brooks WJ; Jarvis MF; Wagner GC
    J Neural Transm; 1989; 76(1):1-12. PubMed ID: 2785159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ; Lipman ZP; Snyder SH
    Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
    Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
    Frei B; Richter C
    FEBS Lett; 1986 Mar; 198(1):99-102. PubMed ID: 3082673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Singer TP; Castagnoli N; Ramsay RR; Trevor AJ
    J Neurochem; 1987 Jul; 49(1):1-8. PubMed ID: 3495634
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial for Parkinson's disease?
    Lewin R
    Science; 1985 Nov; 230(4725):527-8. PubMed ID: 3931220
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductase.
    Poirier J; Barbeau A
    Neurosci Lett; 1985 Nov; 62(1):7-11. PubMed ID: 3877888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S; Ambrosio S; Garofalo P; Gerli P
    Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].
    Lermontiva NN; Soliakov LS; Bachurin SO; Tkachenko SE; Serkova TP
    Biull Eksp Biol Med; 1989 Jun; 107(6):699-701. PubMed ID: 2790166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S; Vincent SR
    Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.
    Kopin IJ
    Environ Health Perspect; 1987 Nov; 75():45-51. PubMed ID: 3319563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Jul; 48(1):87-92. PubMed ID: 6332288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM; Arora PK; Iacofano LA; Harik SI
    Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.